Jazz Total Assets from 2010 to 2024

JAZZ Stock

USD 124.34 2.33 1.84%

Jazz Pharmaceuticals Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2005-12-31

Previous Quarter

11.4 B

Current Value

12.3 B

Quarterly Volatility

4.1 B

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Jazz Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jazz Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 303.9 M, Other Operating Expenses of 3.4 B or Operating Income of 607.5 M, as well as many indicators such as Price To Sales Ratio of 1.93, Dividend Yield of 0.0 or PTB Ratio of 2.98. Jazz financial statements analysis is a perfect complement when working with Jazz Pharmaceuticals Valuation or Volatility modules.

Check out the analysis of Jazz Pharmaceuticals Correlation against competitors.

Latest Jazz Pharmaceuticals' Total Assets Growth Pattern

Below is the plot of the Total Assets of Jazz Pharmaceuticals PLC over the last few years. Total assets refers to the total amount of Jazz Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Jazz Pharmaceuticals PLC books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Jazz Pharmaceuticals' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Jazz Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 11.39 B

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Jazz Total Assets Regression Statistics

	Arithmetic Mean	5,667,610,263
	Geometric Mean	3,542,456,292
	Coefficient Of Variation	73.19
	Mean Deviation	3,291,750,618
	Median	5,123,672,000
	Standard Deviation	4,148,380,530
	Sample Variance	17209061T
	Range	12.1B
	R-Value	0.96
	Mean Square Error	1586428.4T
	R-Squared	0.91
	Slope	887,016,034
	Total Sum of Squares	240926854.3T

Jazz Total Assets History

	2024	12 B
	2023	11.4 B
	2022	10.8 B
	2021	12.3 B
	2020	6.5 B
	2019	5.5 B
	2018	5.2 B

Other Fundumenentals of Jazz Pharmaceuticals PLC

Intangibles To Total Assets

Jazz Pharmaceuticals Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Short Term Investments	Total Liab	Total Current Assets	Intangible Assets	Property Plant Equipment	Current Deferred Revenue	Short Term Debt	Common Stock	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Long Term Investments	Net Working Capital	Capital Stock
Total Assets		0.91	0.96	0.75	0.96	0.98	0.98	0.99	0.11	0.98	0.93	0.98	0.95	0.6	0.63	0.5	-0.88	0.91	0.65	0.96	-0.13	0.9	0.69	0.82	-0.56
Total Stockholder Equity	0.91		0.78	0.93	0.81	0.8	0.89	0.91	0.44	0.82	0.91	0.85	0.9	0.52	0.57	0.65	-0.64	0.88	0.48	0.77	-0.26	0.7	0.76	0.82	-0.45
Net Debt	0.96	0.78		0.59	0.96	0.99	0.92	0.95	-0.08	0.99	0.82	0.98	0.9	0.52	0.54	0.34	-0.96	0.85	0.62	0.97	-0.1	0.94	0.61	0.75	-0.51
Retained Earnings	0.75	0.93	0.59		0.61	0.61	0.74	0.76	0.6	0.63	0.76	0.69	0.81	0.41	0.44	0.59	-0.44	0.77	0.36	0.57	-0.39	0.48	0.73	0.71	-0.3
Accounts Payable	0.96	0.81	0.96	0.61		0.97	0.96	0.95	-0.06	0.98	0.88	0.94	0.94	0.66	0.66	0.39	-0.9	0.84	0.67	0.98	0.02	0.92	0.69	0.75	-0.64
Long Term Debt	0.98	0.8	0.99	0.61	0.97		0.95	0.96	-0.07	1.0	0.86	0.98	0.9	0.54	0.57	0.4	-0.95	0.87	0.66	0.98	-0.1	0.94	0.61	0.76	-0.54
Net Receivables	0.98	0.89	0.92	0.74	0.96	0.95		0.97	0.14	0.96	0.96	0.92	0.94	0.67	0.72	0.47	-0.83	0.88	0.72	0.96	-0.04	0.87	0.71	0.84	-0.64
Good Will	0.99	0.91	0.95	0.76	0.95	0.96	0.97		0.08	0.97	0.9	0.98	0.94	0.59	0.61	0.58	-0.89	0.9	0.68	0.94	-0.19	0.86	0.67	0.76	-0.55
Short Term Investments	0.11	0.44	-0.08	0.6	-0.06	-0.07	0.14	0.08		-0.05	0.32	-0.02	0.14	0.01	0.18	0.19	0.32	0.22	-0.16	-0.08	-0.17	-0.07	0.5	0.48	0.05
Total Liab	0.98	0.82	0.99	0.63	0.98	1.0	0.96	0.97	-0.05		0.88	0.98	0.91	0.59	0.62	0.41	-0.94	0.87	0.69	0.99	-0.07	0.94	0.62	0.77	-0.58
Total Current Assets	0.93	0.91	0.82	0.76	0.88	0.86	0.96	0.9	0.32	0.88		0.83	0.86	0.65	0.76	0.49	-0.68	0.86	0.62	0.88	0.01	0.82	0.71	0.92	-0.62
Intangible Assets	0.98	0.85	0.98	0.69	0.94	0.98	0.92	0.98	-0.02	0.98	0.83		0.93	0.51	0.51	0.47	-0.94	0.88	0.6	0.94	-0.2	0.89	0.63	0.72	-0.48
Property Plant Equipment	0.95	0.9	0.9	0.81	0.94	0.9	0.94	0.94	0.14	0.91	0.86	0.93		0.62	0.59	0.44	-0.82	0.87	0.59	0.9	-0.18	0.81	0.77	0.74	-0.56
Current Deferred Revenue	0.6	0.52	0.52	0.41	0.66	0.54	0.67	0.59	0.01	0.59	0.65	0.51	0.62		0.95	0.15	-0.49	0.42	0.74	0.68	0.47	0.49	0.45	0.45	-0.93
Short Term Debt	0.63	0.57	0.54	0.44	0.66	0.57	0.72	0.61	0.18	0.62	0.76	0.51	0.59	0.95		0.16	-0.45	0.48	0.72	0.7	0.5	0.55	0.48	0.63	-0.91
Common Stock	0.5	0.65	0.34	0.59	0.39	0.4	0.47	0.58	0.19	0.41	0.49	0.47	0.44	0.15	0.16		-0.32	0.62	0.35	0.32	-0.45	0.27	0.34	0.32	-0.05
Net Tangible Assets	-0.88	-0.64	-0.96	-0.44	-0.9	-0.95	-0.83	-0.89	0.32	-0.94	-0.68	-0.94	-0.82	-0.49	-0.45	-0.32		-0.76	-0.65	-0.93	0.1	-0.89	-0.46	-0.55	0.47
Capital Surpluse	0.91	0.88	0.85	0.77	0.84	0.87	0.88	0.9	0.22	0.87	0.86	0.88	0.87	0.42	0.48	0.62	-0.76		0.51	0.82	-0.26	0.86	0.71	0.83	-0.28
Deferred Long Term Liab	0.65	0.48	0.62	0.36	0.67	0.66	0.72	0.68	-0.16	0.69	0.62	0.6	0.59	0.74	0.72	0.35	-0.65	0.51		0.73	0.16	0.52	0.35	0.38	-0.73
Long Term Debt Total	0.96	0.77	0.97	0.57	0.98	0.98	0.96	0.94	-0.08	0.99	0.88	0.94	0.9	0.68	0.7	0.32	-0.93	0.82	0.73		0.05	0.93	0.61	0.76	-0.67
Short Long Term Debt	-0.13	-0.26	-0.1	-0.39	0.02	-0.1	-0.04	-0.19	-0.17	-0.07	0.01	-0.2	-0.18	0.47	0.5	-0.45	0.1	-0.26	0.16	0.05		0.05	-0.11	0.04	-0.51
Net Invested Capital	0.9	0.7	0.94	0.48	0.92	0.94	0.87	0.86	-0.07	0.94	0.82	0.89	0.81	0.49	0.55	0.27	-0.89	0.86	0.52	0.93	0.05		0.57	0.81	-0.44
Long Term Investments	0.69	0.76	0.61	0.73	0.69	0.61	0.71	0.67	0.5	0.62	0.71	0.63	0.77	0.45	0.48	0.34	-0.46	0.71	0.35	0.61	-0.11	0.57		0.7	-0.38
Net Working Capital	0.82	0.82	0.75	0.71	0.75	0.76	0.84	0.76	0.48	0.77	0.92	0.72	0.74	0.45	0.63	0.32	-0.55	0.83	0.38	0.76	0.04	0.81	0.7		-0.41
Capital Stock	-0.56	-0.45	-0.51	-0.3	-0.64	-0.54	-0.64	-0.55	0.05	-0.58	-0.62	-0.48	-0.56	-0.93	-0.91	-0.05	0.47	-0.28	-0.73	-0.67	-0.51	-0.44	-0.38	-0.41

Click cells to compare fundamentals

About Jazz Pharmaceuticals Financial Statements

Jazz Pharmaceuticals investors use historical fundamental indicators, such as Jazz Pharmaceuticals' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Jazz Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	11.4 B	12 B
Intangibles To Total Assets	0.63	0.47

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Jazz Stock Analysis

When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC